Cite
HARVARD Citation
Liu, C. et al. (2021). Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma. Therapeutic advances in medical oncology. p. . [Online].